CABIO will remain committed to the research and production of HMOs, aiming to diversify their applications in the end market and provide a wider range of healthy choices for individuals across different age groups CABIO unveiled an exciting new product range, NeoHMOs™, at the FIE 2023. CABIO team’s successful development[Read More…]
